GW Pharmaceuticals plc announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 152.466 million compared to USD 120.633 million a year ago. Operating loss was USD 21.027 million compared to USD 7.193 million a year ago. Net loss was USD 19.677 million compared to USD 7.965 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.02 a year ago.